Patent · US Expired

Recombinant retinoblastoma-associated protein 1 (E2F-1) polypeptides and cDNA

US5759803A · kind A · utility

5Cited by
0References
42Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 13, 1992
Grant dateJun 2, 1998
Priority date
Expiry dateMay 13, 2012

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K16/18
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

We have discovered a nuclear protein in normal human cells, "retinoblastoma-associated protein 1" ("RBAP-1"), also known as E2F-1, that binds directly to the retinoblastoma protein pocket of the underphosphorylated form of the retinoblastoma protein ("RB") and does not bind to phosphorylated RB or to RB with inactivating mutations. The translated RBAP-1 sequence does not resemble other proteins whose sequences are known, and RBAP-1 does not contain a sequence homologous to the transforming element common to viral proteins that bind to the RB pocket. RBAP-1 and the E2F transcription activity have similar DNA-binding specificities and can bind to at least some of the same proteins, such as RB and E4.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.